Search Results - "Patel, Jai Narendra"

Examination of the Screener and Opioid Assessment for Patients with Pain-Short Form (SOAPP-SF) in an oncology palliative medicine clinic by Greiner, Rebecca, Boselli, Danielle, Salib, Mariam, Patel, Jai Narendra

“…Abstract only 196 Background: The National Comprehensive Cancer Network states opioids can be used to treat cancer pain and prescribers should identify…”
Get full text

Opioid screening and urine toxicology results in outpatient oncology palliative medicine by Patel, Jai Narendra, Jandrisevits, Elizabeth, Boselli, Danielle, Kneuss, Tiffany Gabrielle, Parala-Metz, Armida, Walsh, Declan

“…Abstract only e24068 Background: Opioid misuse is a major public health issue. Given widespread opioid prescribing in cancer patients (pts), screening for…”
Get full text

Impact of Electronically Accessible Pathways (EAPathways) on clinical trial enrollment at a large multisite cancer center by Villadolid, Jeryl Jean, Jandrisevits, Elizabeth, Moore, Donald, Patel, Jai Narendra, Mileham, Kathryn Finch, Kim, Edward S.

“…Abstract only 6517 Background: Clinical pathways streamline evidence-based treatment decisions and provide consistent, high-quality, value-based care. A…”
Get full text

Supportive care medications (SCMs) and pharmacogenomics (PGx) relevance in 6,985 cancer patients (pts) undergoing distress screening by Patel, Jai Narendra, Boselli, Danielle, Jandrisevits, Elizabeth, Hamadeh, Issam, Salem, Ahmed, Meadors, Patrick Leland

“…Abstract only 11592 Background: SCMs are prescribed based on symptom burden, but response is variable, possibly due to PGx. We investigated the association…”
Get full text

Germline thrombophilia gene alterations and thrombosis rates among patients with advanced germ cell tumors treated with chemotherapy by Brown, Landon Carter, Robinson, Myra M., McCormack, Michael Joseph, Steuerwald, Nury, Symanowski, James Thomas, Bose, Rupali, Neelands, Brittany, Akinyelu, Tobi, Livasy, Chad, Li, Wencheng, Haynes, Nathanael C., Grigg, Claud, Raghavan, Derek, Clark, Peter E, Patel, Jai Narendra, Burgess, Earle F

“…e17023 Background: Men with advanced germ cell tumors (GCT) treated with cisplatin-based chemotherapy are at high risk of venous thromboembolism (VTE)…”
Get full text

Venous thromboembolism (VTE) incidence and risk factors in patients (pts) with non-small cell lung cancer (NSCLC) receiving front-line therapy by Patel, Jai Narendra, Robinson, Myra M., Hill, Hailey, Lu, Lauren, Slaughter, Daniel, Kim, Edward S., Amin, Asim, Mileham, Kathryn Finch

“…Abstract only e19293 Background: VTE incidence varies based on factors such as tumor type, stage, and treatment. There is limited data on VTE incidence and…”
Get full text

Identification of genetic markers associated with ibrutinib-related cardiovascular toxicity by Hamadeh, Issam, Jacobs, Ryan, Hu, Bei, Moyo, Tamara Kay, Soni, Amy, Park, Steven I., Patel, Jai Narendra, Steuerwald, Nury, Ghosh, Nilanjan

“…Abstract only 7526 Background: Cardiovascular side effects (CVSEs: atrial fibrillation, hypertension, etc.) are common in patients with chronic lymphocytic…”
Get full text

Real-world experience of an in-house dihydropyrimidine dehydrogenase ( DPYD ) genotype test to guide fluoropyrimidine (FP) dosing at a multisite cancer hospital by Patel, Jai Narendra, Morris, Sarah, Nguyen, Grace, Eboli Lopes, Karine, Hamilton, Alicia, Kwange, Simeon Owuor, Steuerwald, Nury, Moore, Donald, Hanson, Sarah, Larck, Chris, Symanowski, James Thomas, Swift, Kristen, Musselwhite, Laura W., Kadakia, Kunal C., Koya, Brinda, Chai, Seungjean, Osei-Boateng, Kwabena, Kalapurakal, Sini, Hwang, Jimmy J.

“…1534 Background: FPs, including 5-fluorouracil and capecitabine, are widely used to treat solid tumor malignancies like gastrointestinal (GI) cancers…”
Get full text

Efficacy of acupuncture (ACU) therapy for cancer-related pain management in oncology patients (pts) by Patel, Jai Narendra, Miller, Katherine, Symanowski, James Thomas, Edelen, Connie

“…Abstract only 196 Background: Cancer-related pain negatively affects symptom burden, morbidity, and mortality. Evidence suggests the use of ACU to relieve…”
Get full text

Genetic polymorphisms associated with clostridium difficile infection in multiple myeloma patients undergoing autologous stem cell transplantation by Hamadeh, Issam, Shahid, Zainab, Bhutani, Manisha, Patel, Jai Narendra, Steuerwald, Nury, Hamilton, Alicia, Atrash, Shebli, Friend, Reed N., Paul, Barry, Voorhees, Peter Michael, Usmani, Saad Zafar, He, Jiaxian

“…Abstract only 8522 Background: CDI is the primary cause of infectious diarrhea in immunocompromised patients including those undergoing autologous stem cell…”
Get full text

Impact of pharmacy interventions on pain management in an oncology palliative medicine (PM) outpatient clinic by Patel, Jai Narendra, Hamadeh, Issam, Symanowski, James Thomas, Edwards, Rebecca, Susi, Beth, Edelen, Connie

“…Abstract only 119 Background: PM can improve the quality of life and survival for cancer patients (pts); however, the demand for PM challenges providers with…”
Get full text

Pharmacogenetic (PGx) guided cancer pain management in an oncology palliative medicine (PM) clinic by Patel, Jai Narendra, Boselli, Danielle, Symanowski, James Thomas, Wodarski, Stephanie, Turner, ShRhonda, Slaughter, Courtney, Waller, Melissa, Baldassare, Donna, Edwards, Rebecca, Susi, Beth, Greiner, Rebecca, Edelen, Connie

“…Abstract only 117 Background: About 30% of cancer patients presenting with pain have symptomatic improvement using conventional strategies within one month…”
Get full text

Cyclophosphamide (Cy) pharmacogenetics (PGx) in allogeneic stem cell transplant (SCT) patients (pts) receiving Cy, fludarabine, total body irradiation and post-transplant Cy (FluCyTBI-postCy) by Patel, Jai Narendra, Zhang, Qing, Hamadeh, Issam, Steuerwald, Nury, Hamilton, Alicia, Gerber, Jonathan Michael, Grunwald, Michael Richard, Druhan, Lawrence, He, Jiaxian, Avalos, Belinda Rene, Copelan, Edward Alan

“…Abstract only…”
Get full text

Level of burden of supportive care-relevant pharmacogenetic markers in general population by McLeod, Howard L., Patel, Jai Narendra, Wei, Min, Rosenberg, Zeil

“…Abstract only 221 Background: Precision medicine has become part of oncology, with implications for therapy selection, treatment avoidance, dosing, and risk…”
Get full text

The impact of sarcopenia on toxicity and pharmacokinetics of 5-fluorouracil (5FU) in colorectal cancer by Williams, Grant Richard, Deal, Allison Mary, Shachar, Shlomit S., Walko, Christine Marie, Patel, Jai Narendra, O'Neil, Bert H., McLeod, Howard L., Weinberg, Marc, Choi, Seul Ki, Muss, Hyman B., Sanoff, Hanna Kelly

“…Abstract only 633 Background: Great heterogeneity exists in the ability of adults with cancer to tolerate treatment. Variability in body composition may affect…”
Get full text

Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC) by Patel, Jai Narendra, Sehouli, Jahid, Timms, Kirsten, Solimeno, Cara, Reid, Julia E., Lanchbury, Jerry S., Braicu, Ioana, Darb-Esfahani, Silvia, Ganapathi, Mahrukh, Ganapathi, Ram N.

“…Abstract only…”
Get full text

Genotype-directed phase II study of irinotecan dosing in metastatic colorectal cancer (mCRC) patients receiving FOLFIRI + bevacizumab: The GENIC study by Williams, Grant Richard, Innocenti, Federico, Wood, William Allen, Patel, Jai Narendra, Sherrill, Gary Bradley, O'Neil, Bert H., Boles, Jeremiah C., Basch, Ethan M., Sanoff, Hanna Kelly

“…Abstract only…”
Get full text

Evaluation of homeobox (HOX) gene expression as a prognostic biomarker of time to recurrence (TTR) in high grade serous ovarian cancer (HGSOC) patients treated with adjuvant carboplatin plus paclitaxel (A-C/P) by Patel, Jai Narendra, Miller, Katherine Rose, Symanowski, James Thomas, Sehouli, Jalid, Michener, Chad, Braicu, Ioana, Tait, David L., Jones, Wendell, Zhang, Qing, Livasy, Chad, Biscotti, Charles, Ganapathi, Mahrukh Karkaria, Ganapathi, Ram N.

“…Abstract only…”
Get full text

Evaluating variability in fluorouracil (FU) exposure in obese and non-obese patients with colorectal cancer using full weight-based dosing by Patel, Jai Narendra, Deal, Allison Mary, McLeod, Howard L., O'Neil, Bert H., Walko, Christine Marie

“…Abstract only 409 Background: Approximately 30% of cancer patients are obese. Controversy exists on how to best use body weight to safely and effectively dose…”
Get full text

Bevacizumab (BEV) and risk of hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401 (ALLIANCE) by Patel, Jai Narendra, Jiang, Chen, Hertz, Daniel Louis, Mulkey, Flora, Friedman, Paula N., Halabi, Susan, Ratain, Mark J., Morris, Michael J., Small, Eric Jay, Owzar, Kouros, Kelly, William Kevin, McLeod, Howard L.

“…Abstract only…”
Get full text